These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38483443)

  • 21. [The current status and trend of disease burden of neoplasms in 1990 and 2016 for Beijing people].
    Ma AJ; Zhou MG; Zeng XY; Dong Z
    Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):351-356. PubMed ID: 33752317
    [No Abstract]   [Full Text] [Related]  

  • 22. Changes in health in Belgium, 1990-2016: a benchmarking analysis based on the global burden of disease 2016 study.
    Maertens de Noordhout C; Van Oyen H; Speybroeck N; Devleesschauwer B
    BMC Public Health; 2018 Jun; 18(1):775. PubMed ID: 29925365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changing trend regarding the burden on cerebrovascular diseases between 1990 and 2016 in China].
    Peng Q; Li HL; Wang Y; Lu WL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Apr; 40(4):400-405. PubMed ID: 31006198
    [No Abstract]   [Full Text] [Related]  

  • 24. Rheumatic heart disease burden, trends, and inequalities in the Americas, 1990-2017: a population-based study.
    Ordunez P; Martinez R; Soliz P; Giraldo G; Mujica OJ; Nordet P
    Lancet Glob Health; 2019 Oct; 7(10):e1388-e1397. PubMed ID: 31537369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
    Murray CJ; Vos T; Lozano R; Naghavi M; Flaxman AD; Michaud C; Ezzati M; Shibuya K; Salomon JA; Abdalla S; Aboyans V; Abraham J; Ackerman I; Aggarwal R; Ahn SY; Ali MK; Alvarado M; Anderson HR; Anderson LM; Andrews KG; Atkinson C; Baddour LM; Bahalim AN; Barker-Collo S; Barrero LH; Bartels DH; Basáñez MG; Baxter A; Bell ML; Benjamin EJ; Bennett D; Bernabé E; Bhalla K; Bhandari B; Bikbov B; Bin Abdulhak A; Birbeck G; Black JA; Blencowe H; Blore JD; Blyth F; Bolliger I; Bonaventure A; Boufous S; Bourne R; Boussinesq M; Braithwaite T; Brayne C; Bridgett L; Brooker S; Brooks P; Brugha TS; Bryan-Hancock C; Bucello C; Buchbinder R; Buckle G; Budke CM; Burch M; Burney P; Burstein R; Calabria B; Campbell B; Canter CE; Carabin H; Carapetis J; Carmona L; Cella C; Charlson F; Chen H; Cheng AT; Chou D; Chugh SS; Coffeng LE; Colan SD; Colquhoun S; Colson KE; Condon J; Connor MD; Cooper LT; Corriere M; Cortinovis M; de Vaccaro KC; Couser W; Cowie BC; Criqui MH; Cross M; Dabhadkar KC; Dahiya M; Dahodwala N; Damsere-Derry J; Danaei G; Davis A; De Leo D; Degenhardt L; Dellavalle R; Delossantos A; Denenberg J; Derrett S; Des Jarlais DC; Dharmaratne SD; Dherani M; Diaz-Torne C; Dolk H; Dorsey ER; Driscoll T; Duber H; Ebel B; Edmond K; Elbaz A; Ali SE; Erskine H; Erwin PJ; Espindola P; Ewoigbokhan SE; Farzadfar F; Feigin V; Felson DT; Ferrari A; Ferri CP; Fèvre EM; Finucane MM; Flaxman S; Flood L; Foreman K; Forouzanfar MH; Fowkes FG; Fransen M; Freeman MK; Gabbe BJ; Gabriel SE; Gakidou E; Ganatra HA; Garcia B; Gaspari F; Gillum RF; Gmel G; Gonzalez-Medina D; Gosselin R; Grainger R; Grant B; Groeger J; Guillemin F; Gunnell D; Gupta R; Haagsma J; Hagan H; Halasa YA; Hall W; Haring D; Haro JM; Harrison JE; Havmoeller R; Hay RJ; Higashi H; Hill C; Hoen B; Hoffman H; Hotez PJ; Hoy D; Huang JJ; Ibeanusi SE; Jacobsen KH; James SL; Jarvis D; Jasrasaria R; Jayaraman S; Johns N; Jonas JB; Karthikeyan G; Kassebaum N; Kawakami N; Keren A; Khoo JP; King CH; Knowlton LM; Kobusingye O; Koranteng A; Krishnamurthi R; Laden F; Lalloo R; Laslett LL; Lathlean T; Leasher JL; Lee YY; Leigh J; Levinson D; Lim SS; Limb E; Lin JK; Lipnick M; Lipshultz SE; Liu W; Loane M; Ohno SL; Lyons R; Mabweijano J; MacIntyre MF; Malekzadeh R; Mallinger L; Manivannan S; Marcenes W; March L; Margolis DJ; Marks GB; Marks R; Matsumori A; Matzopoulos R; Mayosi BM; McAnulty JH; McDermott MM; McGill N; McGrath J; Medina-Mora ME; Meltzer M; Mensah GA; Merriman TR; Meyer AC; Miglioli V; Miller M; Miller TR; Mitchell PB; Mock C; Mocumbi AO; Moffitt TE; Mokdad AA; Monasta L; Montico M; Moradi-Lakeh M; Moran A; Morawska L; Mori R; Murdoch ME; Mwaniki MK; Naidoo K; Nair MN; Naldi L; Narayan KM; Nelson PK; Nelson RG; Nevitt MC; Newton CR; Nolte S; Norman P; Norman R; O'Donnell M; O'Hanlon S; Olives C; Omer SB; Ortblad K; Osborne R; Ozgediz D; Page A; Pahari B; Pandian JD; Rivero AP; Patten SB; Pearce N; Padilla RP; Perez-Ruiz F; Perico N; Pesudovs K; Phillips D; Phillips MR; Pierce K; Pion S; Polanczyk GV; Polinder S; Pope CA; Popova S; Porrini E; Pourmalek F; Prince M; Pullan RL; Ramaiah KD; Ranganathan D; Razavi H; Regan M; Rehm JT; Rein DB; Remuzzi G; Richardson K; Rivara FP; Roberts T; Robinson C; De Leòn FR; Ronfani L; Room R; Rosenfeld LC; Rushton L; Sacco RL; Saha S; Sampson U; Sanchez-Riera L; Sanman E; Schwebel DC; Scott JG; Segui-Gomez M; Shahraz S; Shepard DS; Shin H; Shivakoti R; Singh D; Singh GM; Singh JA; Singleton J; Sleet DA; Sliwa K; Smith E; Smith JL; Stapelberg NJ; Steer A; Steiner T; Stolk WA; Stovner LJ; Sudfeld C; Syed S; Tamburlini G; Tavakkoli M; Taylor HR; Taylor JA; Taylor WJ; Thomas B; Thomson WM; Thurston GD; Tleyjeh IM; Tonelli M; Towbin JA; Truelsen T; Tsilimbaris MK; Ubeda C; Undurraga EA; van der Werf MJ; van Os J; Vavilala MS; Venketasubramanian N; Wang M; Wang W; Watt K; Weatherall DJ; Weinstock MA; Weintraub R; Weisskopf MG; Weissman MM; White RA; Whiteford H; Wiebe N; Wiersma ST; Wilkinson JD; Williams HC; Williams SR; Witt E; Wolfe F; Woolf AD; Wulf S; Yeh PH; Zaidi AK; Zheng ZJ; Zonies D; Lopez AD; AlMazroa MA; Memish ZA
    Lancet; 2012 Dec; 380(9859):2197-223. PubMed ID: 23245608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD Chronic Kidney Disease Collaboration
    Lancet; 2020 Feb; 395(10225):709-733. PubMed ID: 32061315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 DALYs and HALE Collaborators
    Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Global Burden of Esophageal Cancer: A Disability-Adjusted Life-Year Approach.
    Di Pardo BJ; Bronson NW; Diggs BS; Thomas CR; Hunter JG; Dolan JP
    World J Surg; 2016 Feb; 40(2):395-401. PubMed ID: 26630937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015.
    Sepanlou SG; Parsaeian M; Krohn KJ; Afshin A; Farzadfar F; Roshandel G; Karimkhani C; Bazargan-Hejazi S; Kiadaliri AA; Ahmadieh H; Djalalinia S; Ebrahimi H; Eshrati B; Esteghamati AR; Farvid MS; Fereshtehnejad SM; Hafezi-Nejad N; Hassanvand MS; Heydarpour P; Islami F; Karimi SM; Katibeh M; Khosravi A; Khubchandani J; Mahdavi M; Pishgar F; Qorbani M; Rahimi-Movaghar V; Safi S; Sahraian MA; Shahraz S; Sheikhbahaei S; Mohammadi A; Mokdad AH; Vos T; Murray CJL; Moradi-Lakeh M; Naghavi M; Malekzadeh R
    Arch Iran Med; 2017 Jul; 20(7):403-418. PubMed ID: 28745902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burden of disease among older adults in Europe-trends in mortality and disability, 1990-2019.
    Iburg KM; Charalampous P; Allebeck P; Stenberg EJ; O'Caoimh R; Monasta L; Peñalvo JL; Pereira DM; Wyper GMA; Niranjan V; Devleesschauwer B; Haagsma J
    Eur J Public Health; 2023 Feb; 33(1):121-126. PubMed ID: 36421036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015.
    Karimkhani C; Colombara DV; Drucker AM; Norton SA; Hay R; Engelman D; Steer A; Whitfeld M; Naghavi M; Dellavalle RP
    Lancet Infect Dis; 2017 Dec; 17(12):1247-1254. PubMed ID: 28941561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 fatality and DALYs, and associated metabolic disorders and ambient air pollutants in pre-Omicron era of the pandemic: an international comparative study.
    Ngatu NR; Tonduangu DK; Munyeshyaka E; Hirao T; Balenda GM; Yamadori Y; Deguchi T; Nsadi-Fwene B; Lami JN; Akumwami S; Kanda K; Murakami A; Yandju MC; Nyembue DT; Tshimpi A; Wembonyama SO
    Environ Health Prev Med; 2024; 29():24. PubMed ID: 38599849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Trends of burden on ischemic heart disease and epidemiological transition of related risk factors in China, 1990-2017].
    Wang CR; Meng XF; Wang CP; Liu SW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1703-1709. PubMed ID: 33297630
    [No Abstract]   [Full Text] [Related]  

  • 34. [The disease burden of cardiovascular and circulatory diseases in China, 1990 and 2010].
    Liu J; Liu Y; Wang L; Yin P; Liu S; You J; Zeng X; Zhou M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Apr; 49(4):315-20. PubMed ID: 26081539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal and spatial trends of ischemic heart disease burden in Chinese and subgroup populations from 1990 to 2016: socio-economical data from the 2016 global burden of disease study.
    Wang C; Wang C; Liu M; Chen Z; Liu S
    BMC Cardiovasc Disord; 2020 May; 20(1):243. PubMed ID: 32448161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between expedited review designations and the US or global burden of disease for drugs approved by the US Food and Drug Administration, 2010-2019: a cross-sectional analysis.
    Jackson MJ; Vaughan G; Ledley FD
    BMJ Open; 2024 Mar; 14(3):e076542. PubMed ID: 38471684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in health in the countries of the UK and 150 English Local Authority areas 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Steel N; Ford JA; Newton JN; Davis ACJ; Vos T; Naghavi M; Glenn S; Hughes A; Dalton AM; Stockton D; Humphreys C; Dallat M; Schmidt J; Flowers J; Fox S; Abubakar I; Aldridge RW; Baker A; Brayne C; Brugha T; Capewell S; Car J; Cooper C; Ezzati M; Fitzpatrick J; Greaves F; Hay R; Hay S; Kee F; Larson HJ; Lyons RA; Majeed A; McKee M; Rawaf S; Rutter H; Saxena S; Sheikh A; Smeeth L; Viner RM; Vollset SE; Williams HC; Wolfe C; Woolf A; Murray CJL
    Lancet; 2018 Nov; 392(10158):1647-1661. PubMed ID: 30497795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between sociodemographic status and COPD and asthma mortality, DALY and YLD in southern China, 2005-2015.
    Liao TT; Guan WJ; Zheng YJ; Wang Y; Xiao N; Li C; Xu YJ; He ZX; Meng RL; Zheng XY; Lin LF
    Public Health; 2022 Nov; 212():102-110. PubMed ID: 36306686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Gómez-Dantés H; Fullman N; Lamadrid-Figueroa H; Cahuana-Hurtado L; Darney B; Avila-Burgos L; Correa-Rotter R; Rivera JA; Barquera S; González-Pier E; Aburto-Soto T; de Castro EF; Barrientos-Gutiérrez T; Basto-Abreu AC; Batis C; Borges G; Campos-Nonato I; Campuzano-Rincón JC; de Jesús Cantoral-Preciado A; Contreras-Manzano AG; Cuevas-Nasu L; de la Cruz-Gongora VV; Diaz-Ortega JL; de Lourdes García-García M; Garcia-Guerra A; de Cossío TG; González-Castell LD; Heredia-Pi I; Hijar-Medina MC; Jauregui A; Jimenez-Corona A; Lopez-Olmedo N; Magis-Rodríguez C; Medina-Garcia C; Medina-Mora ME; Mejia-Rodriguez F; Montañez JC; Montero P; Montoya A; Moreno-Banda GL; Pedroza-Tobías A; Pérez-Padilla R; Quezada AD; Richardson-López-Collada VL; Riojas-Rodríguez H; Ríos Blancas MJ; Razo-Garcia C; Mendoza MP; Sánchez-Pimienta TG; Sánchez-Romero LM; Schilmann A; Servan-Mori E; Shamah-Levy T; Téllez-Rojo MM; Texcalac-Sangrador JL; Wang H; Vos T; Forouzanfar MH; Naghavi M; Lopez AD; Murray CJ; Lozano R
    Lancet; 2016 Nov; 388(10058):2386-2402. PubMed ID: 27720260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Benign Prostatic Hyperplasia Collaborators
    Lancet Healthy Longev; 2022 Nov; 3(11):e754-e776. PubMed ID: 36273485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.